BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4120196)

  • 21. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.
    Jose DG; Seshadri R
    Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytotoxic T lymphocytes induced by syngeneic mouse melanoma cells recognize human melanomas.
    Wakabayashi S; Taniguchi M; Tokuhisa T; Tomioka H; Okamoto S
    Nature; 1981 Dec; 294(5843):748-50. PubMed ID: 6976515
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic alterations in tumor cells resulting in their escape from the immune response.
    Hyman R
    Cancer Chemother Rep; 1974; 58(4):431-9. PubMed ID: 4136747
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation.
    Lesley J; Hyman R; Dennert G
    J Natl Cancer Inst; 1974 Dec; 53(6):1759-65. PubMed ID: 4140238
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition by sera and soluble antigens of T-cell-mediated cytotoxicity against leukaemia-associated antigens.
    Ting CC; Rogers MJ
    Nature; 1977 Apr; 266(5604):727-9. PubMed ID: 301609
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-mediated immune mechanisms of tumor cell destruction.
    Perlmann P; O'Toole C; Unsgaard B
    Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of cellular antigens in humoral and cell-mediated immunity as measured in vitro.
    Mawas C; Carey T; Mihich E
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):945-51. PubMed ID: 4128913
    [No Abstract]   [Full Text] [Related]  

  • 28. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.
    Baldwin RW; Embleton MJ; Robins RA
    Int J Cancer; 1973 Jan; 11(1):1-10. PubMed ID: 4133609
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunologic mechanisms in the prevention and therapy of cancer.
    Fleisher TA; Kersey JH
    Am J Dis Child; 1974 Nov; 128(5):739-42. PubMed ID: 4608684
    [No Abstract]   [Full Text] [Related]  

  • 30. [Development in the immunotherapy of malignant melanoma].
    Tritsch H
    Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera.
    Hersey P; Honeyman M; Edwards A; Adams E; McCarthy WH
    Int J Cancer; 1976 Nov; 18(5):564-73. PubMed ID: 62719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunologic reactions in malignant melanoma of the skin in man].
    Veresova OV; Korosteleva TA
    Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
    [No Abstract]   [Full Text] [Related]  

  • 33. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
    Plain MJ; Whitehead RH; Jose DG
    Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunology of cancer: basic experiments and clinical progress (author's transl)].
    Pasternak G
    Arch Geschwulstforsch; 1973; 42(4):345-57. PubMed ID: 4138903
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumour-specific antibody neutralization of factors in rat hepatoma-bearer serum which abrogate lymph-node-cell cytotoxicity.
    Robins RA; Baldwin RW
    Int J Cancer; 1974 Nov; 14(5):589-97. PubMed ID: 4376528
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular immunity and blocking antibodies to tumors.
    Hellström I; Hellström KE
    J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
    [No Abstract]   [Full Text] [Related]  

  • 38. Early onset of serum blocking in a murine melanoma model.
    Bray AE; Holt PG; Roberts LM; Keast D
    Int J Cancer; 1975 Oct; 16(4):607-15. PubMed ID: 1176208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunological interrelationships of the body and the tumor].
    Govallo VI
    Vopr Onkol; 1975; 21(10):93-102. PubMed ID: 52944
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological aspects of human leukaemia.
    Viza D
    Ser Haematol; 1972; 5(5):87-108. PubMed ID: 4133766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.